• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Chindex finalizes big Chinese deal

Article

Distribution service company Chindex International of Bethesda, MD, this month finalized an agreement with China's Ministry of Public Health for the purchase of $14 million of medical equipment. Initiated in July, the agreement resulted from a

Distribution service company Chindex International of Bethesda, MD, this month finalized an agreement with China's Ministry of Public Health for the purchase of $14 million of medical equipment. Initiated in July, the agreement resulted from a partnership between China's Ministry of Health Foreign Loan Office, the U.S. Department of Commerce, the U.S. Export-Import Bank, and China's Ministry of Foreign Trade and Economic Cooperation and State Planning Commission (SCAN 7/22/98).

The deal was financed through a loan to the Bank of China in Beijing from ABN AMRO Bank of the Netherlands, and the loan was guaranteed by the U.S. Export-Import Bank. The transaction represents Chindex's second loan project for U.S. medical equipment.

Vendors included in the agreement are Acuson, Lunar, Steris, Johnson & Johnson Ortho Clinical Diagnostics, Trex Medical/XRE Division, and Nova Biomedical. Shipments of the equipment began in late 1998, and will continue through the first quarter of 1999.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.